missing translation for 'onlineSavingsMsg'
Learn More
Learn More
FK 888, Tocris Bioscience™
Click to view available options
Quantity:
10 mg
Description
Selective, high affinity tachykinin NK1 receptor antagonist (Ki = 0.69 nM) that displays 320-fold selectivity for human over rat NK1 receptors. Inhibits substance P-induced contraction of isolated guinea pig trachea (IC50 = 32 nM) and inhibits substance P-induced airway constriction in vivo following i.v. and oral administration.
![TRUSTED_SUSTAINABILITY](/content/dam/fishersci/glyphs/Sustain_Badge.png)
Specifications
Specifications
CAS | 138449-07-7 |
Molecular Formula | C36H36N4O4 |
Quantity | 10 mg |
Synonym | d05ukk, n 2-4-hydroxy-1-1-methyl-1h-indol-3-yl carbonyl-l-prolyl-n-methyl-n-phenylmethyl-3-2-naphthyl-l-alaninamide, l-alaninamide, trans-4-hydroxy-1-1-methyl-1h-indol-3-yl carbonyl-l-prolyl-n-methyl-3-2-naphthalenyl-n-phenylmethyl, 2s,4r-4-hydroxy-1-1-methylindole-3-carbonyl-n-2s-1-methyl-phenylmethyl amino-3-naphthalen-2-yl-1-oxopropan-2-yl pyrrolidine-2-carboxamide, 2s,4r-n-2s-1-benzyl methyl amino-3-naphthalen-2-yl-1-oxopropan-2-yl-4-hydroxy-1-1-methylindole-3-carbonyl pyrrolidine-2-carboxamide, 4r-4-hydroxy-1-1-methyl-1h-indol-3-yl carbonyl-l-prolyl-n-methyl-3-2-naphthalenyl-n-phenylmethyl-l-alaninamide, l-alaninamide, 4r-4-hydroxy-1-1-methyl-1h-indol-3-yl carbonyl-l-prolyl-n-methyl-3-2-naphthalenyl-n-phenylmethyl |
InChI Key | BFNKQTIJVFGCKQ-PDJGWCFMSA-N |
SMILES | CN1C=C(C2=CC=CC=C21)C(=O)N3CC(CC3C(=O)NC(CC4=CC5=CC=CC=C5C=C4)C(=O)N(C)CC6=CC=CC=C6)O |
IUPAC Name | (2S,4R)-N-[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine-2-carboxamide |
Molecular Weight (g/mol) | 588.708 |
PubChem CID | 107967 |
Formula Weight | 588.69 |
Show More |
Product Suggestions
Customers who viewed this item also viewed
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
FK 888, Tocris Bioscience™ >
Spot an opportunity for improvement?Share a Content Correction